The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis. (2017)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.6b00102
PubMed Identifier: 27726334
Publication URI: http://europepmc.org/abstract/MED/27726334
Type: Journal Article/Review
Volume: 3
Parent Publication: ACS infectious diseases
Issue: 1
ISSN: 2373-8227